Heart failure in women

Area of Science:

• Cardiology
• Women's Health
• Clinical Research

Background:

• Heart failure (HF) is a significant cause of morbidity and mortality in both men and women.
• While incidence is lower in women, HF prevalence is similar, and women face unique challenges including higher hospitalization rates despite better medical compliance.
• Women's quality of life may be disproportionately affected, impacting overall mortality.

Purpose of the Study:

• To highlight the critical need for increased female enrollment in heart failure (HF) clinical trials.
• To emphasize the importance of analyzing sex-specific treatment responses in HF research.
• To address the underrepresentation of women in HF studies and its implications for understanding and treating the condition.

Main Methods:

• Review of existing heart failure clinical trial data regarding female participant enrollment and analysis.
• Assessment of reported outcomes and treatment responses stratified by sex.
• Identification of gaps in research concerning women's specific experiences with heart failure.

Main Results:

• Women are significantly underrepresented in major heart failure clinical trials, with enrollment rarely exceeding 30%.
• Few studies have conducted separate analyses of treatment responses in women versus men.
• Existing data suggest women may have poorer quality of life and higher hospitalization rates despite better adherence to medical therapy.

Conclusions:

• The underrepresentation and lack of sex-specific analysis in HF research limit our understanding of the disease in women.
• Future heart failure research must prioritize large-scale enrollment of women and investigate their unique responses to treatments.
• Addressing these research gaps is crucial for improving the quality of life and outcomes for women with heart failure.